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Approximately 8% of the human genome is comprised of endogenous retroviral insertions
(ERVs) originating from historic retroviral integration into germ cells. The function of
ERVs as regulators of gene expression is well established. Less well studied are
insertional polymorphisms of ERVs and their contribution to the heritability of complex
phenotypes. The most recent integration of ERV, HERV-K, is expressed in a range
of complex human conditions from cancer to neurologic diseases. Using an in-house
computational pipeline and whole-genome sequencing data from the diverse 1,000
Genomes Phase 3 population (n = 2,504), we identified 46 polymorphic HERV-K
insertions that are tagged by adjacent single nucleotide polymorphisms (SNPs). To test
the potential role of polymorphic HERV-K in the heritability of complex diseases, existing
databases were queried for enrichment of established relationships between the HERV-K
insertion-associated SNPs (hiSNPs), and tissue specific gene expression and disease
phenotypes. Overall, hiSNPs for the 46 polymorphic HERV-K sites were statistically
enriched (p <1.0E−16) for eQTLs across 44 human tissues. Fifteen of the 46 HERV-K
insertions had hiSNPs annotated in the EMBL-EBI GWAS Catalog and cumulatively
associated with >100 phenotypes. Experimental factor ontology enrichment analysis
suggests that polymorphic HERV-K specifically contribute to neurologic and immunologic
disease phenotypes, including traits related to intra cranial volume (FDR 2.00E-09),
Parkinson’s disease (FDR 1.80E-09), and autoimmune diseases (FDR 1.80E-09). These
results provide strong candidates for context-specific study of polymorphic HERV-K
insertions in disease-related traits, serving as a roadmap for future studies of the
heritability of complex disease.
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INTRODUCTION
Retroviruses are a class of RNA virus that undergoes reverse
transcription to DNA during the infectious cycle inside a
host cell. At the proviral stage, retroviral DNA integrates
into the host DNA to produce viral proteins. Integration
into germ cells can result in endogenization, wherein the
virus can be vertically transmitted via standard Mendelian
inheritance mechanisms. Endogenous retroviruses (ERV) are
ancient examples of proviruses that integrated and endogenized
into the human genome >40mya (Bannert and Kurth, 2006).
In modern humans, ERVs account for approximately 8% of the
genome (Bannert and Kurth, 2006). Their relative stability, as
well as the conservation of orthologs in other primate genomes
suggests that they induce genome plasticity and can enhance
evolutionary fitness (Cordaux and Batzer, 2009; Feschotte and
Gilbert, 2012; Grow et al., 2015). Retroviruses are reliant on
the fitness of their host for survival and the long-standing
evolutionary cooperation between ERVs and humans may
represent a symbiotic relationship (Jern and Coffin, 2008).
The positive selection of persistent ERVs in the genome may
have resulted from increasing the probability of survival to
reproductive age [via adaptive effects on placentation (Simpson
et al., 1996); and immune (Hurst and Magiorkinis, 2015) and
brain development (Mortelmans et al., 2016)]. The phenotypic
effects of ERVs on the post-reproductive adult, however, remain
unclear and are of growing interest (Li et al., 2015; Bowen et al.,
2016; Sekar et al., 2016).
Previous studies have described the potential mechanisms
by which ERVs influence human phenotypes. ERV insertions
introduce viral genes and, due to their inter-individual
homology can generate copy-number variants via non-allelic
homologous recombination (Campbell et al., 2014). They modify
transcription by adding enhancers (Chuong et al., 2013) and
promoters (Fuchs et al., 2013), disrupting intron structure,
causing RNA interference (Ling et al., 2003) adding poly-
A tails (Kim, 2012), and altering DNA methylation (Kreimer
et al., 2013). ERV expression, typically restricted in healthy
tissues except during placental development, is detected in
diseases including cancers and autoimmune disorders [reviewed
in (Cegolon et al., 2013; Nexø et al., 2016)].
While the functional effects of ERVs are well established,
the vast majority of ERV insertions are fixed across individuals,
and so their potential contribution to phenotypic variation
has been largely overlooked. The HERV-K subfamily, however,
contains human-specific, unfixed insertions, ranging from fully
intact provirus to solo long terminal repeat (LTR) sequences
(Wildschutte et al., 2016). HERV-K represents one of the most
recent ERV integrations into the human genome and numerous
insertions have neither been eliminated from the genome (via
negative selection or drift), nor fixed (via positive selection or
Abbreviations: ERV, endogenous retrovirus; HERV-K, human endogenous
retrovirus-K; SNP single nucleotide polymorphism; hiSNP, HERV-K insertion
associated single nucleotide polymorphism; SVA, sine-VNTR-alu element; eQTL,
expression quantitative trait loci; GWAS, genome-wide association study;
WGS, whole genome sequencing; MDS, multi-dimensional scaling; LD, linkage
disequilibrium.
drift). The polymorphic nature of these insertions suggests a
potential contribution to causal variation in the heritability of
complex phenotypes. Targeted studies have identified specific
HERV-K integrations that affect disease risk, for example
a polymorphic HERV-KC4 inserted within the complement
component 4 (C4A/B) gene appears to be involved in the genetic
risk of schizophrenia (Sekar et al., 2016).
Technical limitations have proved a major obstacle in the
untargeted identification of polymorphic HERV-K insertions
for application to clinical and epidemiologic studies. With
the emergence of next-generation sequencing technologies,
methods are being developed for the untargeted identification
of ERVs among other mobile genetic elements in human
genomes (Witherspoon et al., 2010; Ray and Batzer, 2011;
Wildschutte et al., 2016). Here, we examine phenotypic effects
of all polymorphic HERV-K insertions identifiable from a
large, publically available whole genome sequencing (WGS)
dataset. With our computational pipeline, we identified HERV-
K insertion locations using data from the diverse 1000 Genomes
Phase 3 population (n = 2,504). By identifying a subset of
polymorphic HERV-K insertions with strong associations to
adjacent “tagging” single nucleotide polymorphisms (SNPs), we
have leveraged several comprehensive SNP annotation databases
to test for enrichment of established relationships between
HERV-K insertion-associated SNPs (hiSNPs), tissue-specific gene
expression, and diverse disease phenotypes.
METHODS
HERVnGoSeq Computational Pipeline
To elucidate the broad phenotypic effects of polymorphic
HERV-K insertions, we developed a computational pipeline,
HERVnGoSeq, to identify the presence/absence of known and
novel HERV-K insertions in individual WGS data (Figure S1).
Quality-filtered raw WGS were aligned to HERV-K113, one
of the youngest HERV-K elements in the human genome
with a conserved intact LTR sequence that is also capable of
producing viral particles in vitro (Boller et al., 2008). Reads
that partially aligned to HERV-K113 - chimeric reads - were
trimmed and the non-HERV portions of the reads were extracted.
The trimmed chimeric reads were then aligned to the human
genome (GRCh37/Hg19). The base-pair position of the trimmed
end of the read where HERV-K sequence was removed was
called as the insertion point. Insertion points were collected for
both the forward and reverse complement alignments separately.
Insertion points within 1,000 bp of each other were grouped
to represent a single insertion point. The presence of putative
HERV-K insertions were assigned to each individual if they had
at least one chimeric read that aligned to that insertion point.
Absence of an insertion was inferred for individuals when they
lacked any chimeric reads representing the specific insertion. The
complete pipeline and description is available at https://github.
com/unreno/chimera.
HERV-K Identification/Validation
Putative polymorphic HERV-K elements were nominated via
HERVnGoSeq (Figure S1). Sequence similarity between the
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TABLE 1 | 46 Polymorphic HERV-K insertions with hiSNPs.
Reference HERV-K insertions Non-reference HERV-K insertions
Coordinate GRCh37/hg19 Prevb Average hiSNP Countc Coordinate GRCh37/hg19 Prevb Average hiSNP Countc
chr3:14132679 0.96 453 chr1:106015875 0.04 436
chr3:125609298a 0.54 194 chr1:111802591 0.59 234
chr3:129776131a 0.47 203 chr1:223578304 0.01 206
chr3:195654395 0.96 205 chr4:9603240 0.67 969
chr4:120263688 0.68 1416 chr4:9981605 0.02 650
chr5:8937848 0.83 345 chr5:4537604 0.01 176
chr6:32505702a 0.13 1817 chr5:64388440 0.07 226
chr6:32746812a 0.08 222 chr5:80442266 0.05 49
chr7:16237347a 0.81 259 chr6:32648036 0.35 4965
chr7:158029477 0.28 239 chr6:161270899 0.84 576
chr8:7355392 0.14 108 chr7:158773385 0.01 102
chr8:18651453 0.52 199 chr11:60449890 0.07 292
chr8:37050885 0.32 125 chr12:44313657 0.27 593
chr10:135355522 0.18 155 chr12:124066477 0.13 444
chr11:71478951a 0.82 379 chr13:90743183 0.12 292
chr11:71875417 0.88 117 chr15:63374594 0.68 238
chr12:55727210 0.76 385 chr19:21841536 0.20 613
chr14:20552746a 0.30 144 chr19:22414379 0.43 993
chr17:44361947a 0.17 2300 chr19:22457244 0.01 907
chr19:386675a 0.10 19 chr19:29855781 0.55 536
chr19:52924209a 0.39 37 chr19:57996939 0.02 191
chr20:25215439a 0.84 93 chr20:12402387 0.03 271
chr21:15654234a 0.65 19 chrX:93606603 0.02 186
aNot previously recognized as polymorphic.
bPrev, prevalence averaged across 5 super populations.
cCounts averaged across 5 super populations.
reference index, HERV-K113 LTR, and the HERV-K10 LTR,
which was ancestrally co-opted to form another mobile element
class, Sine-VNTR-Alu composite elements (SVA, Hancks and
Kazazian, 2010), resulted in nomination of insertion sites of SVA-
A, B, and C in addition to HERV-K when the LTR portion of
the SVA element was sufficiently conserved. Thus, true HERV-
K insertion sites nominated by HERVnGoSeq were identified
as follows: HERV-K present in reference—Using the dataset
of mobile genetic elements present in the GRCh37 derived
from RepBase (Bao et al., 2015) (UCSC RepeatMasker track),
HERVnGoSeq nominated sites were confirmed as HERV-K if
mapped within a known HERV-K ± 100 bp. HERV-K absent
from reference—The remaining polymorphic insertion sites were
determined to be HERV-K only if the insertion ± 100 bp was
previously reported and confirmedwith sequencing by a previous
study (Dangel et al., 1994; Barbulescu et al., 1999; Mayer et al.,
1999; Turner et al., 2001; Bennett et al., 2004; Hughes and Coffin,
2004; Macfarlane and Simmonds, 2004; Mamedov et al., 2004;
Belshaw et al., 2005; Moyes et al., 2005; Kidd et al., 2008; Lee et al.,
2012; Marchi et al., 2014; Sudmant et al., 2015; Wildschutte et al.,
2016). Otherwise, they could not be distinguished from SVAs in
silico. Additional HERV-K insertions missed by HERVnGoSeq
but identified by previous studies and genotyped in the 1KG
population were also included (n = 5) (Sudmant et al., 2015;
Wildschutte et al., 2016). Prevalence of each insertion site
was estimated based on either the presence/absence calls from
HERVnGoSeq or from genotypes of HERV-K insertions from
previous studies (n = 5). To ensure that polymorphic HERV-
K insertions could not be explained by larger deletions, each
insertion site was compared to start and end locations of deletions
called in 1KG structural variant VCF. Any HERV-K insertion
with a flanking deletion larger than 1,000 bp could not be reliably
called polymorphic and was excluded from downstream analyses.
Identification of SNPs Associated With
Polymorphic HERV-K Insertions
Most studies of common genetic disease-risk variants published
to-date rely on SNPs, which are easy and cheap to measure
compared to other structural genetic variants. These SNP
studies rely on linkage disequilibrium (LD) wherein the disease-
associated SNP is not necessarily the causal variant but instead
tags the causal variant (outlined in Figure S2). To test our
underlying hypothesis that disease-associated SNPs are, in some
cases, tagging polymorphic HERV-K insertions, which are the
true causal variants, we next identified SNPs associated with each
HERV-K insertion and queried existing SNP:disease databases for
phenotypic associations.
All HERV-K insertion sites were tested for SNP associations.
For each of the 2,504 individuals in 1000 Genomes Phase 3, a
binary indicator of presence/absence of the HERV-K insertion
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FIGURE 1 | Manhattan plot. Results from a genome-wide association study for a polymorphic HERV-K insertion discovered with HERVnGoSeq at chr1:111802591.
The gray horizontal line represents the threshold for genome-wide significance of 5 ×10−8. Logistic regression was performed separately within each of the five super
populations in the 1,000 Genomes. AFR, African; AMR, Ad Mixed American; EAS, East Asian; EUR, European; SAS, South Asian.
was generated via HERVnGoSeq or by recoding genotypes
generated from previous publications (Sudmant et al., 2015;
Wildschutte et al., 2016). Variant files for 1000 Genomes
Phase 3 were downloaded from the FTP site (NCBI FTP site:
ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp). After stratifying
by continental population and removing related individuals
(Gazal et al., 2015), all biallelic SNPs present in the 1,000
Genomes Phase 3 variant files were tested for association with
the presence of each of the polymorphic HERV-K insertions
using logistic regression adjusted for population stratification
by including the first 6 multidimensional scaling (MDS) vectors
in all models. MDS components were generated from all 1,000
Genomes variants following pruning for common SNPs (minor
allele frequency MAF > 0.05) and for independence followed
by random thinning to 10% of variants. All logistic regression
modeling and MDS estimation were conducted in Plink 1.9
(Chang et al., 2015).
Manhattan plots were generated to visualize associations
between genome-wide SNPs and polymorphic HERV-K
insertions. For each of the “taggable” HERV-K insertion sites
(i.e., those that showed a single, strong association peak in the
Manhattan plot), hiSNPs were defined as all SNPs within a
1Mb window of the insertion with p-value for association less
than or equal to the Bonferroni adjusted p-value threshold for
significance (0.05/Total SNPs in 1Mb window).
Sensitivity of hiSNP Set Generation
To confirm that the binary HERV-K insertion presence/absence
calls made by HERVnGoSeq generated hiSNP sets similar to
hiSNPs for HERV-K insertions called using a different pipeline,
we identified 12 HERV-K insertions detected by HERVnGoSeq
and the 1000 Genomes by Sudmant et al. (2015). For the
12 HERV-K insertion sites detected by HERVnGoSeq and
genotyped by Sudmant et al., logistic regression-based SNP
associations were estimated from the binary HERVnGoSeq
calls and the dichotomized 1,000 Genomes genotype calls
within Europeans. hiSNPs generated by HERVnGoSeq and 1,000
Genomes calls using themethod described above were compared.
To ensure that hiSNPs associated by logistic regression were
representative of SNPs that are in LD with polymorphic HERV-
K insertions, complete genotype data for the 12 overlapping
HERVnGoSeq/1,000 Genomes sites were used to identify tagging
SNPs via the r2 measure of LD, defined as having an r2 > 0.2.
Expression Quantitative Trait Loci (eQTL)
Polymorphic HERV-K insertion hiSNPs across all HERV-K
insertion sites were pooled and tested for eQTL (SNP-gene
expression association with p < 0.05 adjusted for multiple tests)
enrichment against all common SNPs included in the tissue-
specific Genotype-Tissue Expression (GTEx) Project Version
6 (n = 11,555,102) (Carithers and Moore, 2015) using a
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FIGURE 2 | (A) Ideogram. Relative genomic locations of HERV-K insertion
locations with (green) and without (blue) hiSNPs identified via HERVnGoSeq.
(B) Histogram. Frequency distribution of identified HERV-K insertion
prevalences for insertions with (green) and without (blue) hiSNPs.
Fisher’s exact test. The null hypothesis for this test is that
the odds ratio ([hiSNP&eQTL]x[Not hiSNP&Not eQTL])/([Not
hiSNP&eQTL]x[Not eQTL&hiSNP])= 1. Enrichment of hiSNPs
annotated as GTEx eQTLs were also calculated separately by
HERV-K insertion site and tissue type using Fisher’s exact tests.
Genome-Wide Association and
Experimental Factor Ontology Enrichment
To investigate whether hiSNPs for the polymorphic HERV-
K insertion sites have established phenotypic associations,
the EMBL-EBI GWAS Catalog (MacArthur et al., 2017)
was queried for the presence of hiSNPs. To test for
broader phenotypic enrichment across the HERV-K
insertion sites, experimental factor ontology enrichment
analyses were conducted for all pooled hiSNPs using the
XGR online tool (http://galahad.well.ox.ac.uk:3020) with
significant enrichments having a false discovery rate <
0.05.
SNP Density
To determine whether the absence of hiSNPs for some HERV-
K insertions sites was due to the absence of any proximal
SNPs, SNP density was calculated for all insertion sites. All
SNPs in the 1,000 Genomes Phase 3 dataset were counted
within a 1MB, 500Kb, and 100Kb window centered on
each polymorphic HERV-K insertion site. The mean SNP
densities for HERV-K insertions with hiSNPs was compared
to HERV-K insertions with prevalence estimates from 0.2-0.8
and no hiSNPs using a Student’s t-Test. Two HERV-K sites
located in unlocalized contigs (chr1_gl00192_random) were
excluded.
Hotspot Distance
To examine whether some HERV-K insertions lacked hiSNPs
due to their proximity to recombination hotspots, we selected
two recombination hotspot maps and calculated the distance
between the HERV-K insertion sites and recombination hotspots.
We identified two datasets mapping the genomic locations of
recombination hotspots genome-wide—one using a population-
average LD-based mapping method (4,697 hotspots, Genomes
Project et al., 2010) and the other using ChIP-seq to identify
PRDM9 binding sites among five individuals (62,110 hotspots,
Pratto et al., 2014). Repeated random sampling with replacement
was used to estimate the distribution of mean distances
between randomly selected genomic locations and the nearest
recombination hotspot. In order to compare this distribution to
the distribution of distances of polymorphic HERV-Ks, a pool of
random genomic locations was created wherein locations were
matched to the HERV-K sites by chromosome and GC content
of flanking 2Kb region. HERV-K insertion sites on chromosome
Y and unmapped contigs were excluded (n = 11). First, the
percentage GC content of the 2 kb flanking each HERV-K was
calculated using data from the UCSC gc5Base Track (Karolchik
et al., 2004) in Hg19. Next, all chromosomes were divided into
2Kb segments and percentage GC content was calculated for
each. GC content for all segments was calculated to the tenth of
a percent. For each HERV-K insertion, 2 Kb genomic segments
were added to the sampling pool if they had identical GC content
and were on the same chromosome. This resulted in an average
of 444 random locations from which to sample for each HERV-
K site (∼187,000 total). From this pool, 172 random genomic
locations (defined as the center of the 2Kb fragment), matched
1:1 to respective HERV-K insertions, were sampled and the mean
distance to nearest recombination hotspots were calculated. This
sampling procedure was repeated 1,000 times. The entire process
was carried out independently with each of the recombination
hotspot maps.
RESULTS
Polymorphic HERV-K Identification
Our computational pipeline, HERVnGoSeq, nominated 1,381
putative HERV-K insertion sites among 2,504 human whole
genomes from the 1000 Genomes Phase 3 population where
sequencing reads partially aligned to the HERV-K113 LTR.
HERV-K113 represents the one of the most recent HERV-K
integration and thus is most likely to be polymorphic and to
have preserved function (Turner et al., 2001). Of the 1,381
sites, 403 HERV-K insertions mapped to reference HERV-K
breakpoint sequences in GRCh37/Hg19. A total of 783 putative
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FIGURE 3 | Heat map of log-transformed p-values for enrichment of hiSNPs that are eQTLs. Includes the 30 polymorphic HERV-K insertion sites with strong SNP
associations in the European continental population. Enrichment of SNPs that are both hiSNPs and eQTLs was determined using Fisher’s exact test. Results are
stratified across 44 human tissue types.
sites mapped to reference SINE-alu-VNTR (SVA) insertions and
were discarded. Of the remaining 195 non-reference putative
insertions, 28 had been previously annotated and confirmed
as HERV-K via sequencing in recent studies (Sudmant et al.,
2015; Wildschutte et al., 2016) and the remainder, many of
which are likely SVA, will require future targeted sequencing to
confirm. With the rapidly increasing rate of discovery of HERV-
K insertions in human genomes, we were able to collate an
additional 5 HERV-K insertion sites discovered in a parallel study
(Wildschutte et al., 2016), which were also genotyped in the 1000
Genomes population. In total, the 431 (403 reference and 28 non-
reference) HERV-K insertions were tested for SNP associations
(Table S1). The dichotomized presence/absence, rather than
genotypes, of the nominated 431 HERV-K insertion sites were
tested for SNP associations to reduce potential misclassification
induced by poor sensitivity of calls due to low sequencing depth
(∼4x). An additional 16 HERV-K insertion sites identified in
independent populations of diseased individuals [The Cancer
Genome Atlas (Marchi et al., 2014); dbRIP (Wang et al., 2006)]
were not detected by HERVnGoSeq, nor any parallel study
utilizing the 1000 Genomes Project, suggesting that the diversity
of HERV-K insertion sites expands beyond what is represented in
the 1000 Genomes population.
hiSNP Identification
All HERV-K insertions detected in more than one individual (n
= 431) were tested for SNP associations using logistic regression.
HERVnGoSeq did not identify any HERV-K insertions occurring
in 100% of 2,504 individuals; however, low coverage sequencing
data likely resulted in an underestimation of the prevalence
of some insertion sites. Thus it is likely that some sites
with high prevalence called by HERVnGoSeq are actually
fixed across populations. Genome-wide logistic regression
stratified by continental population and adjusted for genetic
ancestry revealed 46 polymorphic HERV-K insertion sites with
significant SNP associations (hiSNPs) in at least one continental
population after correction for multiple testing (Table 1,
Table S2, Figures S3–S50). Figure 1 shows a Manhattan plot of
the genome-wide SNP association results for a polymorphic
HERV-K insertion located on chromosome 1.
Of these, 13 were not previously known to be polymorphic.
The majority of the remaining 385 HERV-K insertion sites with
no identifiable hiSNPs were rare (prevalence < 0.2, n = 48),
singletons (n= 14), or common and potentially fixed (prevalence
> 0.8, n = 190), which may explain the lack of association
with neighboring SNPs. However, 129 HERV-K sites appear to
be common and unfixed (prevalence restricted to 0.2–0.8) yet
have no hiSNPs and thus could not be evaluated for phenotype
enrichment in this study (Figure 2).
Among the 46 HERV-K insertion sites with strong SNP
associations, hiSNP sets were selected within a 1-megabase
window to ensure that no strongly associated SNPs were excluded
arbitrarily due to genomic distance. The median number of
hiSNPs associated with each of these 46 HERV-K insertions was
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FIGURE 4 | Manhattan plots. Plots of hiSNP sets for 15 HERV-K insertion sites among the 30 polymorphic HERV-K insertion sites with strong SNP associations in the
European continental population. Vertical black lines denote HERV-K insertion locations. hiSNPs that are annotated in the NHGRI-EBI GWAS Catalog are represented
by red points.
279 (Table 1). A complete summary including odds ratio and
p-values for all hiSNP-HERV-K associations can be found in
Table S3.
To ensure that the selected hiSNPs represented SNPs in true
linkage disequilibrium with the HERV-K insertions, a subset
of 12 sites that were identified by HERVnGoSeq and also
genotyped in an independent study of structural variation in
the 1,000 Genomes Project (Sudmant et al., 2015) were selected
for sensitivity analyses. hiSNP sets selected by HERVnGoSeq
were compared to hiSNP sets derived from logistic regression
with outcome being dichotomized genotypes of insertions
called by the 1,000 Genomes, and LD via r2 values based on
maximum likelihood phasing. HERVnGoSeq logistic regression-
based hiSNP sets consistently nominated the greatest number
of hiSNPs across the 12 sites and, for 10 sites, >75% of
HERVnGoSeq hiSNPs were also hiSNPs derived from the
genotyped insertions via logistic regression or r2 (Table S2,
Figures S51–S63).
Tissue-Specific Differential Gene
Expression and Disease Enrichment
The Genotype-Tissue expression (GTEx) project provides
expression quantitative trait loci (eQTL) analysis results from
genotype and gene expression data derived from 449 individuals
across 44 human tissues (Carithers and Moore, 2015). We
tested whether the HERVnGoSeq derived hiSNPs for each of
the HERV-K insertion sites were enriched for eQTLs based on
these data. Because the GTEx individuals are ∼85% white, we
restricted these analyses to the hiSNP sets identified among the 30
polymorphic HERV-K insertion sites in the European continental
population (Table S1) to reduce confounding by population
stratification. We observed enrichment (p < 0.05) of hiSNPs
for eQTLs in at least one tissue type for 22 of the 30 sites by
Fisher’s exact test (Figure 3). HERV-K insertion sites contributed
the most eQTL associations to subcutaneous adipose tissue and
thyroid tissue with 15 HERV-K sites each. Fifteen of the sites
with hiSNP sets enriched for eQTLs also include SNPs associated
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with disease by GWAS (Figure 3). The number of genes for
which individual HERV-K insertion hiSNPs served as eQTLs
ranged from 1 to 75 (Table S4). Often in the instances where
a large number of genes were affected, the HERV-K insertion
and genes occurred on blocks of extended LD (i.e., the major
histocompatibility complex).
We next examined the 30 hiSNP sets identified in the
European continental population for annotation in the NHGRI-
EBI GWAS Catalog. Half of the HERV-K insertion sites had at
least one hiSNP with a genome-wide significant association with
a disease phenotype (Figure 4). In total, European polymorphic
HERV-K insertions are associated with 80 human phenotypes
(Table 2).
Experimental factor ontology enrichment analysis suggests
that polymorphic HERV-K insertions broadly associate with
neurologic and immunologic disease phenotypes, including traits
related to intracranial volume (FDR 4.40E-08), Parkinson’s
disease (FDR 1.80E-09), and autoimmune diseases (FDR 1.80E-
09) (Table S5, Figure S64).
Analyses of “Untaggable” HERV-K
Insertion Sites
The majority of polymorphic HERV-K insertions identified via
HERVnGoSeq were not associated with any nearby SNPs (n
= 129) and could not be evaluated for existing phenotypic
associations in this study. Fifty-three of these HERV-K insertions
(estimated mean prevalence: 45.6%, range: <1–79.7%), occur
within genes (Table S6).
The distribution of polymorphic HERV-K in specific
chromosomal regions (ex: telomeres, centromeres) did not
explain the lack of strong hiSNP associations in the 129 identified
polymorphic sites (Figure 2A). However, we suspected that
they might differ from sites with strong SNP associations in
two respects—proximal SNP density and distance to nearest
recombination hotspots, which both effect neighboring patterns
of LD (Ardlie et al., 2002; Ke et al., 2004). We found significantly
lower SNP densities in the areas around HERV-K insertion sites
without hiSNPs (mean 2813.2) than the areas around HERV-K
insertions with hiSNPs (mean 3392.7, difference in means: 579.5
SNPs, p = 0.0007). However, the presence of SNPs flanking
the 129 HERV-K insertions without hiSNPs suggests that SNP
density is not a sufficient determining factor.
ERVs can be involved in homologous and non-homologous
recombination events (Campbell et al., 2014). Some are enriched
for PRDM9 binding motifs (Campbell et al., 2014) and
elimination through recombination is a major mechanism
by which ERV sequences are removed from the human
genome (Katzourakis et al., 2007). We investigated whether
recombination at HERV-K insertion sites explained the lack
of hiSNP associations with these 129 HERV-K insertions by
measuring their proximity to known recombination hotspots.
HERV-K insertion sites without hiSNP associations were
farther on average from mapped recombination hotspots than
their hiSNP-associated counterparts (222.2 kb difference in
distance to LD hotspots, p = 0.04, and 40.1 kb difference
in distance to ChIP-seq hotspots, p = 0.008). To determine
whether the distance of polymorphic HERV-K insertions from
recombination hotspots was greater than expected by chance,
we compared the mean distance of these 172 polymorphic
HERV-K insertions (46 with hiSNPs and 129 without) to the
distances from hotspots of repeated random samples of 172
genomic locations. To mitigate potential confounding, random
genomic locations were matched to HERV-K insertions sites
on chromosome and flanking 2 kb GC content. Polymorphic
HERV-K without hiSNPs were farther from recombination
hotspots than randomly selected genomic locations (p <
0.005), whereas insertions with hiSNPs were not farther (or
closer) to recombination hotspots than expected by chance
(Figure 5).
DISCUSSION
This study shows that polymorphic HERV-K insertions occur
in regions of the genome enriched for phenotypic function
and, furthermore, that these insertion variants co-occur
with established disease-risk variants, providing previously-
untested candidates for the functional elements underlying
the heritability of numerous complex diseases. Using our
computational pipeline, HERVnGoSeq, and the diverse 1,000
Genomes population, we confirmed the presence of 33 known
polymorphic HERV-K insertions and identified an additional
13 confirmed sites via strong SNP associations not previously
recognized as polymorphic. Of the total 46 HERV-K insertions
under investigation, 22 have hiSNP sets enriched for eQTLs
and 15 contained disease-associated SNPs identified in prior
GWAS.
The collective evidence put forth by annotated hiSNPs
supports a role for HERV-K insertions in inducing phenotypic
effects. There is previous evidence that polymorphic HERV-
K insertions may affect brain function. Previous studies have
established links between HERV-K and amyotrophic lateral
sclerosis (Alfahad and Nath, 2013), HIV-associated dementia
(Garrison et al., 2007), and Schizophrenia (Sekar et al., 2016).
Our results further support these links and provide specific
candidate polymorphisms that may explain these observations.
We found two polymorphic HERV-K insertions (chr5:64388440
and chr6:32648036) whose hiSNP sets include a GWAS hit for
schizophrenia. The association of the hiSNP at the insertion
chr6:32648036 has already been attributed to the presence
of a polymorphic HERV-K at the complement component 4
(C4) locus, resulting in altered expression at C4A and C4B,
which we also observed in our eQTL enrichment results
(Table S4) (Sekar et al., 2016). The hiSNP set at the second
site at chr5:64388440 contains a SNP that is associated with
schizophrenia symptoms relating to hallucination, delusion, and
paranoia (Fanous et al., 2012) and both the SNP and the
HERV-K are located directly upstream of and serve as eQTLs
for ADAMTS6, a gene among a family that experimentally
induces neurite growth in cultured neurons (Hamel et al.,
2008). One of the most strongly associated hiSNPs for another
HERV-K at chr4:120263688 was previously identified in a
GWAS examining the genetics of cognitive performance using
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TABLE 2 | HERV-K insertions with hiSNPs annotated in NHGRI-EBI GWAS Catalog and associated traits.
HERV-K insertion Disease/Trait SNP IDa PMIDb
Non-MHC HERV-K insertion sites
chr1:111802591 Interferon alpha levels in systemic lupus
erythematosus
rs7411387*** (OR = 1.61) 25338677
chr4:120263688 Corneal astigmatism rs11098499** (β = 0.048) 23322567
Educational attainment rs10028773*** (β = 0.02) 25201988
chr5:64388440 Schizophrenia rs17206232* (β = 0.135) 23212062
chr5:8937853 Obesity-related traits rs11134338** (β = 0.03) 23251661
chr6:161270898 Lipoprotein (a) - cholesterol levels rs1620921*** 25575512
Lipoprotein (a) levels rs9355814 (β = 0.33), rs783147 (β = 0.3) 26377243, 21900290
Protein quantitative trait loci rs7770628 18464913
chr10:135355522 Obesity-related traits rs2249694 (β = 0.03) 23251661
chr12:124066477 Pubertal anthropometrics rs786425* (β = 0.06) 23449627
chr12:55727213 Contrast sensitivity rs12230513* (β = 2.69) 24152035
chr13:90743183 Longevity rs2882281 20834067
chr15:63374594 Blood metabolite levels rs1472631 (β = 0.037) 24816252
Mean platelet volume rs11071720 (β = 0.061) 19820697
Metabolic traits rs2652822 (β = 0.085) 21886157
Platelet count rs3809566 (β = 2.43x10-9) 22139419
Social communication problems rs17828380 (β = 0.18) 24564958
chr17:44361947 Bone mineral density rs1864325 (β = 0.04) 22504420
Corticobasal degeneration rs12185268 (OR = 1.3) 26077951
Epithelial ovarian cancer rs183211 (OR = 1.11) 25581431
Idiopathic pulmonary fibrosis rs17690703 (OR = 1.43) 24429156
Interstitial lung disease rs1981997 (OR = 1.41) 23583980
Intracranial volume rs9303525 (β = 14.9) 22504418
Male-pattern baldness rs12373124 (OR = 1.33) 22693459
Ovarian cancer in BRCA1 mutation carriers rs183211 (OR = 1.25) 23544013
Parkinson’s disease rs12185268 (OR = 3.46), rs17577094 (OR = 1.56),
rs17649553 (OR = 1.3), rs183211, rs199515 (OR =
1.32), rs199533 (OR = 1.28), rs415430, rs8070723
(OR = 1.3)
21738487, 24842889, 25064009,
21812969, 22451204, 20711177,
21812969, 21044948
Progressive supranuclear palsy rs8070723 (OR = 5.11) 21685912
Subcortical brain region volumes rs17689882 (β = 13460.47), rs8072451 (β =
14489.99)
25607358, 25607350
chr19:22414379 Body mass index (change over time) rs8105895** (β = 1.26) 25378290
Chagas cardiomyopathy in Tripanosoma cruzi
seropositivity
rs2262909 24324551
Dental caries rs10404998**, rs1865075**, rs931608* 23259602, 23259602, 23064961
Response to statin therapy (LDL-C) rs931608* (β = 4.2) 22331829
Telomere length rs1975174*** (β = 0.05), rs412658*** (β = 0.0497) 20421499, 23001564
MHC Herv-K insertion sites
chr6:32505702 Cervical cancer rs9272143 (OR = 1.49) 28806749
Hepatitis B vaccine response rs3135363 (OR = 1.53) 24282030
Hepatitis C induced liver cirrhosis rs3135363 (OR = 1.37) 23321320
Hepatocellular carcinoma rs9272105 (OR = 1.28) 22807686
Leishmaniasis (visceral) rs9271858 (OR = 1.41) 23291585
Response to interferon beta therapy rs9272105 (β = 0.026) 21502966
Rheumatoid arthritis rs2157337* 21156761
Systemic sclerosis rs3129763 (OR = 1.65) 21779181
(Continued)
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TABLE 2 | Continued
HERV-K insertion Disease/Trait SNP IDa PMIDb
chr6:32648036 Alzheimer’s disease (late onset) rs9271192 (OR = 1.1) 24162737
Antinuclear antibody levels rs2395185** (β = 0.25) 25186300
Arthritis (juvenile idiopathic) rs2395148 (OR = 5.37) 18576341
Asthma rs3117098 (OR = 1.16), rs7775228*** (OR = 1.17),
rs9268516* (OR = 1.15), rs9272346* (OR = 1.16)
21804548, 21804548, 23028483,
29273806
Asthma and hay fever rs9273373* (OR = 1.24) 24388013
Atopic dermatitis rs9469099 (OR = 1.61) 23042114
Chronic lymphocytic leukemia rs674313 (OR = 1.69) 21131588
Circulating myeloperoxidase levels (serum) rs3134931 (β = 0.05) 23620142
Cystic fibrosis severity rs9268905** 21602797
Dementia and core Alzheimer’s disease
neuropathologic changes
rs7453498* (β = 0.814) 25188341
Epstein-Barr virus immune response (EBNA-1) rs477515** (β = 0.28) 23326239
Follicular lymphoma rs12195582 (OR = 1.78), rs2647012* (OR = 1.56) 25279986, 21533074
Hepatitis B vaccine response rs477515** (OR = 2.05) 24282030
Hepatitis C induced liver cirrhosis rs3817963* (OR = 1.3) 23321320
Hepatocellular carcinoma (hepatitis B virus related) rs9275319** (OR = 1.49) 23242368
Hodgkin’s lymphoma rs2395185** (OR = 1.82), rs6903608* (OR = 1.64) 22286212, 24920014
Hypothyroidism rs3129720 (OR = 1.16) 22493691
IgA nephropathy rs2856717* (OR = 1.27), rs660895* (OR = 1.29),
rs7763262 (OR = 1.41), rs9275596* (OR = 1.44)
25305756, 26028593, 25305756,
25305756
IgE grass sensitization rs7775228*** (OR = 1.33) 22036096
Inflammatory bowel disease rs477515** (OR = 1.38) 18758464
Leprosy rs9271100 (OR = 1.68) 25642632
Lung adenocarcinoma rs3817963* (OR = 1.18) 22797724
Lung cancer rs2395185** 23143601
Lupus nephritis in systemic lupus erythematosus rs2647012* (OR = 1.52) 24925725
Lymphoma rs2647045*** (OR = 1.69), rs2647046* (OR = 1.25),
rs9268853** (OR = 1.56)
23349640, 23349640, 23349640
Multiple sclerosis (OCB status) rs3129720 (OR = 1.91), rs3817963* (OR = 1.61),
rs9275563
23472185, 23472185, 23472185
Narcolepsy (age of onset) rs7744020* (β = 1.9) 24204295
Nasopharyngeal carcinoma rs28421666* (OR = 1.49) 20512145
Nephropathy rs9275596* (OR = 1.59) 21399633
Neurofibrillary tangles rs34075049** (β = 0.59) 25188341
Parkinson’s disease rs2395163 (OR = 1.24), rs9275326 (OR = 1.18) 22451204, 28892059
Peanut allergy rs9275596* (OR = 1.7) 25710614
Primary biliary cirrhosis rs7774434*** (OR = 1.57) 22961000
Rheumatoid arthritis rs12194148*, rs12525220 (OR = 2.61), rs660895*
(OR = 3.62), rs7748270 (OR = 1.74), rs9268839*
(OR = 2.28), rs9275406 (OR = 2.1)
21156761, 24782177,17804836,
24782177, 24390342, 23918589
Sarcoidosis rs2076530 22936702
Schizophrenia rs9274623 (OR = 1.14) 26198764
Sjogren’s syndrome rs9271588 24097066
Systemic lupus erythematosus rs2647012* (OR = 1.38), rs9271100 (OR = 1.9) 21408207, 19838193
Systemic sclerosis rs9275390 (OR = 2.38) 21779181
Type 1 diabetes rs9272346* (OR = 5.49) 17554300
Ulcerative colitis rs1063355* (OR = 1.43), rs2395185** (OR = 1.49),
rs6927022* (OR = 1.44), rs9268480* (OR = 1.82),
rs9268853** (OR = 1.37), rs9268877** (OR = 1.45),
rs9268923** (OR = 1.45)
24837172, 20228799, 23128233,
19915573, 23511034, 18836448,
20228798
(Continued)
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TABLE 2 | Continued
HERV-K insertion Disease/Trait SNP IDa PMIDb
Vitiligo rs3806156** (OR = 1.42) 20410501
Waist-hip ratio rs2076529 (β = 0.02) 20935629
Waist-to-hip ratio adjusted for body mass index rs7759742* (β = 0.02) 28443625
chr6:32746812 Kawasaki disease rs2857151 (OR = 1.47) 22446962
a* denotes strength of HERV-K::hiSNP association, all p-values are< bonferroni threshold *p< 1.0e−10, **p< 1.0e−15, ***p< 1.0e−20. OR/β value from SNP: Phenotype association.
bPMID, Pubmed ID for original research article in GWAS Catalog describing the SNP-phenotype association.
proxy-phenotypes (Rietveld et al., 2014). Experimental factor
ontology enrichment analysis of hiSNPs also suggested a
largely neurological phenotypic effect of polymorphic HERV-K
wherein Parkinson’s disease, intracranial volume, and temporal
arteritis were the seconds, third, and fourth most significantly
enriched terms, respectively. Enrichment analysis also suggests
that HERV-K insertion sites may have a functional role in
autoimmune diseases. The role of polymorphic HERV-K in
immunity, particularly insertions within the HLA, is difficult to
delineate. While no specific associations have been established
between HERV-K and autoimmunity, strong evidence suggests
a link between multiple sclerosis and expression of HERV-W
(Schmitt et al., 2013); and the role of ERVs in autoimmunity
has been long suspected, but its study has been hindered by
technological limitations.With the increasing availability of next-
generation sequencing data and computational methods like
HERVnGoSeq, the time is ripe for a thorough investigation of
polymorphic HERVs in autoimmune disease.
HERV-K expression has frequently been noted in human
cancers and has also been of interest as an etiologic factor.
We found hiSNP associations with Hepatocellular carcinoma
(HCC) tagging two polymorphic HERV-K insertions. Recent
studies identified an increase in HERV-K expression in HCC vs.
normal tissue (Ma et al., 2016) and also discovered that HCC
tumor mutations are frequently caused by APOBEC enzymes,
a component of the human innate immune system primarily
active against ERVs (Chiu and Greene, 2008). As such, the role
of polymorphic HERV-K in interaction with hepatitis viruses and
HCC appears warranted.
The HERV-K LTR is known to contain enhancer elements
and thus the degree to which hiSNPs were enriched for eQTLs
was not unexpected. An advantage of using the GTEx database is
the ability to determine tissue-specific eQTL activity, which can
help discern the phenotypic effects of polymorphic HERV-K. For
example, we observe that the hiSNPs for a polymorphic HERV-
K at chr19:22414379 are enriched for eQTLs in adipose tissue,
suggesting that the insertion could affect fat storage. Indeed, the
hiSNP set for this insertion also contains a GWAS SNP associated
with changes in body mass index over time (McQueen et al.,
2015).
It is possible that the HERV-K with hiSNP eQTL enrichment
is not itself the variant altering cis-gene expression, particularly
in cases where the HERV is inserted on a large LD block, for
example within the HLA region (chr6:32505702, chr6:32648036,
chr6:32746812). Often these regions are not fully explored in
functional follow-up studies due to their complexity. Since
HERV-K LTRs contain functional elements, they serve as
strong candidates for eQTLs regardless of regional complexity,
warranting additional studies. It is also possible that the observed
relationships between eQTLs and HERV-K insertions differ
across populations. However, the GTEx consortium primarily
consists of samples derived from european individuals and
thus the relationship between polymorphic HERV-K and gene
expression can currently only be inferred in this population.
We could not leverage SNP annotations to illuminate the
function of the majority of polymorphic HERV-K insertions
because they did not associate with any neighboring SNPs. In
addition to the 46 HERV-K insertions with hiSNPs, we also
nominated 129 reference HERV-K insertions that are likely
polymorphic and that may have yet-undetected phenotypic
associations. It is possible that some of the lower prevalence
sites without hiSNPs are fixed and were called polymorphic
only because of poor detection sensitivity of HERVnGoSeq.
However, this seems unlikely, as our prevalence estimates
for previously recognized non-reference polymorphic HERV-
K were usually within ∼10% of previous studies’ estimates
(Figure S65). Pairwise correlations of SNPs directly adjacent
to these HERV-K insertions suggest that there is LD in these
regions (data not shown), but that the HERV-K insertions are
“dark variants” that are not correlated with proximal SNPs.
One potential explanation why the majority of polymorphic
HERV-K insertions fail to have strong SNP associations is the
greater than expected distance to the nearest recombination
hotspot. Patterns of LD are known to strengthen the closer
variants are to a hotspot, with complete loss of LD within the
hotspot itself. The observed decay of HERV:SNP LD farther
from hotspots requires further study. It is also possible that
there is hotspot activity near or within these HERVs that
were not identified and included in the two hot spot maps
used for this study. Breakdown of LD patterns surrounding
these HERV-K insertions may also be explained by other
mechanisms that could not be investigated in the present
study, including frequent sporadic non-allelic homologous
recombination events, evolutionarily recent integration, off-
target mutagenic activity of HERV-K repressors such as APOBEC
enzymes, or hypermethylation resulting in sporadic deamination
of methylated cytosines.
In our survey of phenotypic associations with polymorphic
HERV-K insertions, the greatest limitation was the poor
sensitivity of detection of HERV-K due to the low coverage of
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FIGURE 5 | Mean distance to nearest recombination hotspot. Distances indicated for polymorphic HERV-K insertions with and without hiSNPs (dashed lines) and the
distribution of mean distances of random genomic locations matched to HERV-K insertions on proximal GC content and chromosome. Distributions were derived
from 1000 repeated random samples with replacement. (A) Distances from nearest ChIP-seq-based recombination hotspot, (B) Distances from nearest LD-based
recombination hotspot.
the sequencing data available for the 1,000 Genomes population.
Consequently, we were not able to call genotypes or estimate
prevalence with high precision. Similar pipelines that have used
these data to genotype mobile genetic elements often include
an imputation step. Our observation, that a significant number
of HERV-K insertions lack SNP associations, likely impedes
the ability and reliability of imputation-based methods for
genotyping these polymorphisms. This may also explain why
so few members of the HERV-K family have been recognized
as polymorphic. We anticipate that the accuracy of genotyping
HERV-K insertions will greatly increase with higher coverage
sequencing data.
Polymorphic HERV-K elements are associated with the germ-
line risk of myriad phenotypes. While this study provides
a starting point for further investigation, disease-specific
epidemiologic and functional studies are needed to elucidate
the role of specific polymorphic HERV-K insertions in complex
diseases.
ETHICS STATEMENT
This study was carried out in accordance with the
recommendations of our institutional review board at both
the University of California, San Francisco and University
of Nevada, Reno. The protocol was approved by the
UCSF and UNR IRB (IRB# 1178149-1, 992935-1). Only
previously collected data was used in this analysis where
Frontiers in Genetics | www.frontiersin.org 12 August 2018 | Volume 9 | Article 298
Wallace et al. Polymorphic HERV-K and Complex Human Phenotypes
original investigators required all subjects gave written
informed consent in accordance with the Declaration of
Helsinki.
AUTHOR CONTRIBUTIONS
SF and AW conceived of the study, conducted and assisted
in analysis, and wrote the paper. GW developed bioinformatic
pipelines, managed data, and assisted in manuscript preparation.
LB, AdS, KW, CM, JC, JW assisted in analyses, provided
technical expertise and aided in manuscript preparation and
writing.
FUNDING
We thank our funders (NIH/NCI 5T32CA151022-05 PI:Costello,
NIH/NIGMS 1R15GM126562-01 PI:Francis), and the countless
other studies generating publicly available data to further our
understanding of disease.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fgene.
2018.00298/full#supplementary-material
REFERENCES
Alfahad, T., and Nath, A. (2013). Retroviruses and amyotrophic lateral sclerosis.
Antiviral Res. 99, 180–187. doi: 10.1016/j.antiviral.2013.05.006
Ardlie, K. G., Kruglyak, L., and Seielstad, M. (2002). Patterns of linkage
disequilibrium in the human genome. Nat. Rev. Genet. 3, 299–309.
doi: 10.1038/nrg777
Bannert, N., and Kurth, R. (2006). The evolutionary dynamics of human
endogenous retroviral families. Annu. Rev. Genomics Hum. Genet. 7, 149–173.
doi: 10.1146/annurev.genom.7.080505.115700
Bao, W. D., Kojima, K. K., and Kohany, O. (2015). Repbase update, a
database of repetitive elements in eukaryotic genomes. Mob. DNA 6:11.
doi: 10.1186/s13100-015-0041-9
Barbulescu, M., Turner, G., Seaman, M. I., Deinard, A. S., Kidd, K. K., and Lenz,
J. (1999). Many human endogenous retrovirus K (HERV-K) proviruses are
unique to humans.Curr. Biol. 9, 861–868. doi: 10.1016/S0960-9822(99)80390-X
Belshaw, R., Dawson, A. L., Woolven-Allen, J., Redding, J., Burt, A.,
and Tristem, M. (2005). Genomewide screening reveals high levels of
insertional polymorphism in the human endogenous retrovirus family HERV-
K(HML2): implications for present-day activity. J. Virol. 79, 12507–12514.
doi: 10.1128/JVI.79.19.12507-12514.2005
Bennett, E. A., Coleman, L. E., Tsui, C., Pittard, W. S., and Devine, S. E. (2004).
Natural genetic variation caused by transposable elements in humans. Genetics
168, 933–951. doi: 10.1534/genetics.104.031757
Boller, K., Schonfeld, K., Lischer, S., Fischer, N., Hoffmann, A., Kurth, R., et al.
(2008). Human endogenous retrovirus HERV-K113 is capable of producing
intact viral particles. J. Gen. Virol. 89, 567–572. doi: 10.1099/vir.0.83534-0
Bowen, L. N., Tyagi, R., Li, W., Alfahad, T., Smith, B., Wright, M., et al.
(2016). HIV-associated motor neuron disease: HERV-K activation
and response to antiretroviral therapy. Neurology 87, 1756–1762.
doi: 10.1212/WNL.0000000000003258
Campbell, I. M., Gambin, T., Dittwald, P., Beck, C. R., Shuvarikov, A., Hixson,
P., et al. (2014). Human endogenous retroviral elements promote genome
instability via non-allelic homologous recombination. BMC Biol. 12:74.
doi: 10.1186/s12915-014-0074-4
Carithers, L. J., and Moore, H. M. (2015). The genotype-tissue expression (GTEx)
project. Biopreserv. Biobank. 13, 307–308. doi: 10.1089/bio.2015.29031.hmm
Cegolon, L., Salata, C., Weiderpass, E., Vineis, P., Palù, G., and Mastrangelo, G.
(2013). Human endogenous retroviruses and cancer prevention: evidence and
prospects. BMC Cancer 13:4. doi: 10.1186/1471-2407-13-4
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., and Lee, J. J.
(2015). SecondS-generation PLINK: rising to the challenge of larger and richer
datasets. Gigascience 4:7. doi: 10.1186/s13742-015-0047-8
Chiu, Y. L., and Greene, W. C. (2008). The APOBEC3 cytidine deaminases:
an innate defensive network opposing exogenous retroviruses and
endogenous retroelements. Annu. Rev. Immunol. 26, 317–353.
doi: 10.1146/annurev.immunol.26.021607.090350
Chuong, E. B., Rumi, M. A., Soares, M. J., and Baker, J. C. (2013). Endogenous
retroviruses function as species-specific enhancer elements in the placenta.Nat.
Genet. 45, 325–329. doi: 10.1038/ng.2553
Cordaux, R., and Batzer, M. A. (2009). The impact of retrotransposons on human
genome evolution. Nat. Rev. Genet. 10, 691–703. doi: 10.1038/nrg2640
Dangel, A.W., Mendoza, A. R., Baker, B. J., Daniel, C. M., Carroll, M. C.,Wu, L. C.,
et al. (1994). The dichotomous size variation of human-complement C4 genes
is mediated by a novel family of endogenous retroviruses, which also establishes
species-specific genomic patterns among old-world primates. Immunogenetics
40, 425–436. doi: 10.1007/BF00177825
Fanous, A. H., Zhou, B., Aggen, S. H., Bergen, S. E., Amdur, R. L.,
Duan, J., et al. (2012). Genome-wide association study of clinical
dimensions of schizophrenia: polygenic effect on disorganized symptoms.
Am. J. Psychiatry 169, 1309–1317. doi: 10.1176/appi.ajp.2012.120
20218
Feschotte, C., and Gilbert, C. (2012). Endogenous viruses: insights into viral
evolution and impact on host biology. Nat. Rev. Genet. 13, 283–296.
doi: 10.1038/nrg3199
Fuchs, N. V., Loewer, S., Daley, G. Q., Izsvák, Z., Löwer, J., and Löwer, R. (2013).
Human endogenous retrovirus K (HML-2) RNA and protein expression is a
marker for human embryonic and induced pluripotent stem cells. Retrovirology
10:115. doi: 10.1186/1742-4690-10-115
Garrison, K. E., Jones, R. B., Meiklejohn, D. A., Anwar, N., Ndhlovu,
L. C., Chapman, J. M., et al. (2007). T cell responses to human
endogenous retroviruses in HIV-1 infection. PLoS Pathog. 3:e165.
doi: 10.1371/journal.ppat.0030165
Gazal, S., Sahbatou, M., Babron, M. C., Génin, E., and Leutenegger, A. L. (2015).
High level of inbreeding in final phase of 1000 genomes project. Sci. Rep.
5:17453. doi: 10.1038/srep17453
Genomes Project, C., Abecasis, G. R., Altshuler, D., Auton, A., Brooks, L. D.,
Durbin, R. M., et al. (2010). A map of human genome variation from
population-scale sequencing. Nature 467, 1061–1073. doi: 10.1038/nature
09534
Grow, E. J., Flynn, R. A., Chavez, S. L., Bayless N. L., Wossidlo M., Wesche
D. J., et al. (2015). Intrinsic retroviral reactivation in human preimplantation
embryos and pluripotent cells. Nature 522, 221–225. doi: 10.1038/nature14308
Hamel, M. G., Ajmo, J. M., Leonardo, C. C., Zuo, F., Sandy, J. D., and Gottschall,
P. E. (2008). Multimodal signaling by the ADAMTSs (a disintegrin and
metalloproteinase with thrombospondin motifs) promotes neurite extension.
Exp. Neurol. 210, 428–440. doi: 10.1016/j.expneurol.2007.11.014
Hancks, D. C., and Kazazian, H. H. Jr. (2010). SVA retrotransposons:
evolution and genetic instability. Semin. Cancer Biol. 20, 234–245.
doi: 10.1016/j.semcancer.2010.04.001
Hughes, J. F., and Coffin, J. M. (2004). Human endogenous retrovirus
K solo-LTR formation and insertional polymorphisms: implications for
human and viral evolution. Proc. Natl. Acad. Sci. U.S.A. 101, 1668–1672.
doi: 10.1073/pnas.0307885100
Hurst, T. P., and Magiorkinis, G. (2015). Activation of the innate immune
response by endogenous retroviruses. J. Gen. Virol. 96, 1207–1218.
doi: 10.1099/vir.0.000017
Jern, P., and Coffin, J. M. (2008). Effects of retroviruses on host genome function.
Annu. Rev. Genet. 42, 709–732. doi: 10.1146/annurev.genet.42.110807.0
91501
Frontiers in Genetics | www.frontiersin.org 13 August 2018 | Volume 9 | Article 298
Wallace et al. Polymorphic HERV-K and Complex Human Phenotypes
Karolchik, D., Hinrichs, A. S., Furey, T. S., Roskin, K. M., Sugnet, C. W., Haussler,
D., et al. (2004). The UCSC table browser data retrieval tool. Nucleic Acids Res.
32, D493–D96. doi: 10.1093/nar/gkh103
Katzourakis, A., Pereira, V., and Tristem, M. (2007). Effects of recombination
rate on human endogenous retrovirus fixation and persistence. J. Virol. 81,
10712–10717. doi: 10.1128/JVI.00410-07
Ke, X., Hunt, S., Tapper, W., Lawrence, R., Stavrides, G., Ghori, J., et al. (2004). The
impact of SNP density on fine-scale patterns of linkage disequilibrium. Hum.
Mol. Genet. 13, 577–588. doi: 10.1093/hmg/ddh060
Kidd, J. M., Cooper, G. M., Donahue, W. F., Hayden, H. S., Sampas, N., Graves, T.
et al. (2008). Mapping and sequencing of structural variation from eight human
genomes. Nature 453, 56–64. doi: 10.1038/nature06862
Kim, H. S. (2012). Genomic impact, chromosomal distribution and
transcriptional regulation of HERV elements. Mol. Cells 33, 539–544.
doi: 10.1007/s10059-012-0037-y
Kreimer, U., Schulz, W. A., Koch, A., Niegisch, G., and Goering,W. (2013). HERV-
K and LINE-1 DNA methylation and reexpression in urothelial carcinoma.
Front. Oncol. 3:255. doi: 10.3389/fonc.2013.00255
Lee, E., Iskow, R., Yang, L. X., Gokcumen, O., Haseley, P., Luquette, L. J. III., et al.
(2012). Landscape of somatic retrotransposition in human cancers. Science 337,
967–971. doi: 10.1126/science.1222077
Ling, J., Pi, W., Yu, X., Bengra, C, Long, Q, Jin, H et al. (2003). The ERV-9 LTR
enhancer is not blocked by the HS5 insulator and synthesizes through the HS5
site non-coding, long RNAs that regulate LTR enhancer function.Nucleic Acids
Res. 31, 4582–4596. doi: 10.1093/nar/gkg646
Li, W., Lee, M. H., Henderson, L., Tyagi, R., Bachani, M., Steiner, J., et al. (2015).
Human endogenous retrovirus-K contributes to motor neuron disease. Sci.
Transl. Med. 7:307ra153. doi: 10.1126/scitranslmed.aac8201
MacArthur, J., Bowler, E., Cerezo, M., Gil, L., Hall, P., Hastings, E., et al. (2017).
The new NHGRI-EBI Catalog of published genome-wide association studies
(GWASCatalog).Nucleic Acids Res. 45, D896–D901. doi: 10.1093/nar/gkw1133
Macfarlane, C., and Simmonds, P. (2004). Allelic variation of HERV-K(HML-
2) endogenous retroviral elements in human populations. J. Mol. Evol. 59,
642–656. doi: 10.1007/s00239-004-2656-1
Mamedov, I., Lebedev, Y., Hunsmann, G., Khusnutdinova, E., and Sverdlov, E.
(2004). A rare event of insertion polymorphism of aHERV-K LTR in the human
genome. Genomics 84, 596–599. doi: 10.1016/j.ygeno.2004.04.010
Marchi, E., Kanapin, A., Magiorkinis, G., and Belshaw, R. (2014). Unfixed
endogenous retroviral insertions in the human population. J. Virol. 88,
9529–9537. doi: 10.1128/JVI.00919-14
Ma, W. J., Hong, Z. F., Liu, H. L., Chen, X., Ding, L., Liu, Z., et al. (2016). Human
endogenous retroviruses-K (HML-2) Expression is correlated with prognosis
and progress of hepatocellular carcinoma. Biomed. Res. Int. 2016:8201642.
doi: 10.1155/2016/8201642
Mayer, J., Sauter, M., Rácz, A., Scherer, D., Mueller-Lantzsch, N., and
Meese, E. (1999). An almost-intact human endogenous retrovirus
K on human chromosome 7. Nat. Genet. 21, 257–258. doi: 10.103
8/6766
McQueen, M. B., Boardman, J. D., Domingue, B. W., Smolen, A., Tabor, J., Killeya-
Jones, L., et al. (2015). The national longitudinal study of adolescent to adult
health (add health) sibling pairs genome-wide data. Behav. Genet. 45, 12–23.
doi: 10.1007/s10519-014-9692-4
Mortelmans, K., Wang-Johanning, F., and Johanning, G. L. (2016). The role of
human endogenous retroviruses in brain development and function. APMIS
124, 105–115. doi: 10.1111/apm.12495
Moyes, D. L., Martin, A., Sawcer, S., Temperton, N., Worthington, J., Griffiths,
D. J., et al. (2005). The distribution of the endogenous retroviruses
HERV-K113 and HERV-K115 in health and disease. Genomics 86, 337–341.
doi: 10.1016/j.ygeno.2005.06.004
Nexø, B. A., Villesen, P., Nissen, K. K., Lindegaard, H. M., Rossing, P., Petersen,
T., et al. (2016). Are human endogenous retroviruses triggers of autoimmune
diseases? unveiling associations of three diseases and viral loci. Immunol. Res.
64, 55–63. doi: 10.1007/s12026-015-8671-z
Pratto, F., Brick, K., Khil, P., Smagulova, F., Petukhova, V. G., Camerini-Otero, D.
R., et al. (2014). Recombination initiation maps of individual human genomes.
Science 346:826. doi: 10.1126/science.1256442
Ray, D. A., and Batzer, M. A. (2011). Reading TE leaves: new approaches to the
identification of transposable element insertions. Genome Res. 21, 813–820.
doi: 10.1101/gr.110528.110
Rietveld, C. A., Esko, T., Davies, G., Pers, T. H., Turley, P., Benyamin, B.,
et al. (2014). Common genetic variants associated with cognitive performance
identified using the proxy-phenotype method. Proc. Natl. Acad. Sci. U.S.A. 111,
13790–13794. doi: 10.1073/pnas.1404623111
Schmitt, K., Richter, C., Backes, C., Meese, E., Ruprecht, K., and Mayer, J. (2013).
Comprehensive analysis of human endogenous retrovirus group HERV-W
locus transcription in multiple sclerosis brain lesions by high-throughput
amplicon sequencing. J. Virol. 87, 13837–13852. doi: 10.1128/JVI.02388-13
Sekar, A., Bialas, A. R., de Rivera, H., Avery Davis, A., Hammond, R. T., Kamitaki,
N., et al. (2016). Schizophrenia risk from complex variation of complement
component 4. Nature 530, 177–183. doi: 10.1038/nature16549
Simpson, G. R., Patience, C., Löwer, R., Tönjes, R. R., Moore, H. D., Weiss, R. A.,
et al. (1996). Endogenous D-type (HERV-K) related sequences are packaged
into retroviral particles in the placenta and possess open reading frames for
reverse transcriptase. Virology 222, 451–456. doi: 10.1006/viro.1996.0443
Sudmant, P. H., Rausch, T., Gardner, E. J., Handsaker, R. E., Abyzov, A,
Huddleston, J., et al. (2015). An integrated map of structural variation in 2,504
human genomes. Nature 526, 75–81. doi: 10.1038/nature15394
Turner, G., Barbulescu, M., Su, M., Jensen-Seaman, M. I., Kidd, K. K., and Lenz,
J. (2001). Insertional polymorphisms of full-length endogenous retroviruses
in humans. Curr. Biol. 11, 1531–1535. doi: 10.1016/S0960-9822(01)00
455-9
Wang, J., Song, L., Grover, D., Azrak, S., Batzer, M. A., and Liang, P. (2006). dbRIP:
a highly integrated database of retrotransposon insertion polymorphisms in
humans. Hum. Mutat. 27, 323–329. doi: 10.1002/humu.20307
Wildschutte, J. H., Williams, Z. H., Montesion, M., Subramanian, R. P., Kidd, J. M.,
and Coffin, J. M. (2016). Discovery of unfixed endogenous retrovirus insertions
in diverse human populations. Proc. Natl. Acad. Sci. U.S.A. 113, E2326–E2334.
doi: 10.1073/pnas.1602336113
Witherspoon, D. J., Xing, J., Zhang, Y., Watkins, W. S., Batzer, M. A., and
Jorde, L. B. (2010). Mobile element scanning (ME-Scan) by targeted high-
throughput sequencing. BMC Genomics 11:410. doi: 10.1186/1471-2164-1
1-410
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Wallace, Wendt, Barcellos, de Smith, Walsh, Metayer, Costello,
Wiemels and Francis. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) and the
copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Genetics | www.frontiersin.org 14 August 2018 | Volume 9 | Article 298
